US$ 27.50
gip/glp-1 receptor agonist drugs list Free Comparison Chart: GLP-1 and Agonists for Type 2 Diabetes π Link in bio #FOAMed #Type2Diabetes #GLP1 Semaglutide vs. Other GLP-1 Receptor
Description
Jang Won Son 1 , Soo Lim 2 Endocrinology and Metabolism 2024;39(2):206-221

Nature 633 , 758760 (2024)

doi: 10.1016/j.amjmed.2014.04.017 144 AzzizRCarminaEChenZDunaifALavenJSLegroRSet al

1 Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of medications that were first approved in 2005 for type 2 diabetes (T2D)

Additionally, geographic bias may limit generalizability: a potential geographic bias exists, as a substantial proportion of the included trials were conducted in North America and Europe, limiting generalizability to underrepresented populations in Asia, Africa, and South America
